Challenges for HIV Pre-Exposure Prophylaxis among Men Who Have Sex with Men in the United States

article has not abstract

Vyšlo v časopise: Challenges for HIV Pre-Exposure Prophylaxis among Men Who Have Sex with Men in the United States. PLoS Med 9(8): e32767. doi:10.1371/journal.pmed.1001286
Kategorie: Essay
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001286

Souhrn

article has not abstract

Zdroje

1. GrantRM, LamaJR, AndersonPL, McMahanV, LiuAY, et al. (2010) Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Eng J Med 363: 2587–2599.

2. Thigpen MC, Kebaabetswe PM, Smith DK, Segolodi TM, Soud FA, et al.. (2011) Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 study [abstract WELBC01]. IAS Conference on HIV Pathogenesis,Treatment, and Prevention; July 2011; Rome, Italy.

3. University of Washington, International Clinical Research Center (2011) Pivotal study finds that HIV medications are highly effective as prophylaxis against HIV infection in men and women in Africa [press release]. 13 July 2011. Available: http://depts.washington.edu/uwicrc/research/studies/files/PrEP_PressRelease-UW_13Jul2011.pdf. Accessed 1 March 2012.

4. ManserghG, KoblinBA, ColfaxGN, McKirnanDJ, FloresSA, et al. (2010) Preefficacy use and sharing of antiretroviral medications to prevent sexually-transmitted HIV infection among US men who have sex with men. J Acquir Immune Defic Syndr 55 (2) e14–e16.

5. Sullivan P, Liu A, Fuchs J, Irby R, Tarver R, et al.. (2011) Awareness of and intention to use PrEP: a post-iPrEX survey of US MSM. National HIV Prevention Conference; August 2011; Atlanta.

6. KoblinBA, ManserghG, FryeV, TieuHV, HooverDR, et al. (2011) Condom use decision making in the context of hypothetical pre-exposure prophylaxis efficacy among substance-using men who have sex with men: Project MIX. J Acquir Immune Defic Syndr 58 (3) 319–327.

7. BuchbinderSP, LiuA (2011) Pre-exposure prophylaxis and the promise of combination prevention approaches. AIDS Behav Supp 1: S72–S79.

8. MyersGM, MayerKH (2011) Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings. AIDS Patient Care STDs 25: 63–71.

9. UnderhillK, OperarioD, MimiagaMJ, SkeerMR, MayerKH (2010) Implementation science of pre-exposure prophylaxis: preparing for public use. Curr HIV/AIDS Rep 7: 210–219.

10. Mayer K, Mimiaga M, White J, Krakower D Vanderwarker R (2011) Knowledge, attitudes, and beliefs of Massachusetts physicians regarding topical and oral antiretroviral chemoprophylaxis. Conference on Retroviral and Opportunistic Infections; February 2011; Boston. Session 195, abstract 1000.

11. MimiagaMJ, CaseP, JohnsonCV, SafrenSA, MayerKH (2009) Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr 50: 77–83.

12. US Centers for Disease Control and Prevention (2011) Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. Morbid Mortal Weekly Rep 60: 65–68 Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a1.htm?s_cid=mm6003a1_w. Accessed 1 March 2012.

13. AmicoKR (2011) Standard of care for antiretroviral therapy adherence and retention in care from the perspective of care providers attending the 5th International Conference on HIV Treatment Adherence. J Int Assoc Physicians AIDS Care (Chic) 10 (5) 291–296.

14. AbbasUL, HoodG, WetzelAW, MellorsJW (2011) Factors influencing the emergence and spread of HIV drug resistance arising from rollout of antiretroviral pre-exposure prophylaxis (PrEP). PLoS ONE 6 (4) e18165 doi:10.1371/journal.pone.0018165.

15. SupervieV, BarrettM, KahnJS, MusakaG, MoetiTL, et al. (2011) Modeling dynamic interactions between PrEP interventions and treatment programs: predicting HIV transmission and resistance. Sci Rep 1: 185.

16. PaltielAD, FreedbergKA, ScottCA, SchackmanBR, LosinaE, et al. (2009) HIV preexposure prophylaxis in the United States: Impact on lifetime infection risk, clinical outcomes, and cost effectiveness. Clin Infect Dis 48: 806–815.

17. CohenMS, ChenYQ, McCauleyM, GambleT, HosseinipourMC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Eng J Med 365 (6) 493–505.